Showing results (111-120 of 229) with videos related to

Sort By:
Pageof 23
Urology|June 9, 2004
Eosinophilic cystitis after bladder instillation with dimethyl sulfoxideYoram Abramov, Roger P Goldberg, Michael McGuire, et al.
American Journal of Obstetrics and Gynecology|July 1, 2008
Treatment modalities, health care resource utilization, and costs in patients diagnosed with interstitial cystitisEdward J Stanford, Andrew Chen, George J Wan, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|June 5, 2009
Efficacy and tolerability of fesoterodine in women with overactive bladderPeter K Sand, Jon D Morrow, Tamara Bavendam, et al.
Drugs & Aging|January 27, 2012
Long-term safety, tolerability and efficacy of fesoterodine in subjects with overactive bladder symptoms stratified by age: pooled analysis of two open-label extension studiesPeter K Sand, John Heesakkers, Stephen R Kraus, et al.
Current Medical Research and Opinion|March 2, 2011
Long-term safety, tolerability, and efficacy of fesoterodine treatment in men and women with overactive bladder symptomsHarriette Scarpero, Peter K Sand, Con J Kelleher, et al.
Urology|July 13, 2004
Foley versus intermittent self-catheterization after transvaginal sling surgery: which works best?Sanjay Gandhi, Jennifer L Beaumont, Roger P Goldberg, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|September 4, 2009
Trospium chloride extended release is effective and well tolerated in women with overactive bladder syndromePeter K Sand, Roger R Dmochowski, Norman R Zinner, et al.
American Journal of Obstetrics and Gynecology|June 23, 2005
Extended-release formulations of oxybutynin and tolterodine exhibit similar central nervous system tolerability profiles: a subanalysis of data from the OPERA trialFranklin M Chu, Roger R Dmochowski, Daniel J Lama, et al.
Neurourology and Urodynamics|January 25, 2018
The efficacy of botulinum toxin A and sacral neuromodulation in the management of interstitial cystitis (IC)/bladder pain syndrome (BPS), what do we know? ICI-RS 2017 think thank, BristolMohammad S Rahnama'i, Tom Marcelissen, Apostolos Apostolidis, et al.
Neurourology and Urodynamics|May 12, 2011
Effects of voluntary dose escalation in a placebo-controlled, flexible-dose trial of fesoterodine in subjects with overactive bladderDavid Staskin, Vik Khullar, Martin C Michel, et al.
Pageof 23